VERTICAL ECOMMERCE Europe’s Leading Online Pharmacy SPEAKER PROFILE KEY COMPANY FACTS • Olaf is a CEO of DocMorris and Head of Germany Key Corporate Facts Valuation Data and Key Financials • Serving on the Management Board of DocMorris since Headquarters Steckborn, Switzerland Market Cap €729m 2008 and as CEO since 2009, additionally appointed Founded 1993 Head for Germany within the Zur Rose Group in 2017 Employees 1,000+ 2017A 2018E Growth • Before joining DocMorris, he managed joint ventures Revenues €m 868 1,069 23% in the retail (KarstadtQuelle/Redcats) and Active Markets International EBITDA €m (19) (7) pharmaceutical (Medco Celesio) sectors and held Ownership Public (SIX) other international senior management positions with Frey Beat Family, Al Faisaliah Margin % (2%) (1%) leading companies in the retail and pharmaceutical Key Shareholders Group, T. Rowe Price EV/Revenue 0.8x 0.6x (19%) Olaf Heinrich sectors Company Deck Click here to download EV/EBITDA - - - • He studied industrial engineering in Berlin and London Website zurrosegroup.com Board Member & Key Operating KPIs CEO of DocMorris Active Customers H1 2018 3.1m DocMorris DocMorris Repeat Order Rate H1 2018 84% DocMorris Average Basket Size H1 2018 €67 COMPANY PROFILE ZUR ROSE GROUP @ NOAH • Operating under the Zur Rose and DocMorris brands, the Swiss-based Zur Doing Business @ NOAH Main Presentation Topics Rose Group is Europe’s leading online pharmacy and one of Switzerland’s Present your business proposal through Fireside chat with foremost wholesale suppliers to medical practitioners. Through our business model, we help to ensure safe, reliable and high-quality pharmaceutical care. NOAH Connect app We also excel in developing innovative medicines management services to increase the effectiveness of the medication process • This creation of added value, our strong focus on patients and our commitment to supply pharmaceuticals at low cost make our Group an important strategic partner for healthcare providers, payers and industry Attendees @NOAH • The Zur Rose Group is headquartered in Frauenfeld, which is also the base for serving the Swiss market. Customers in Germany and Austria we primarily Olaf Heinrich, Board Member supply from Heerlen (Netherlands). Furthermore, we hold a majority interest in BlueCare in Winterthur, the leading provider of networking systems in the Swiss healthcare marketEmploying more than 1,000 people at our various locations, the Zur Rose Group generated revenue of CHF 983 million in 2017. Zur Rose Group AG’s shares are traded on the SIX Swiss Exchange Note: Valuation and financial data according to S&P Capital IQ (as of 25/09/2018). 141